IDEXX inVue Dx Cellular Analyzer
See cells like never before.
Diagnose and act on clinically important cell types in real time with a slide-free workflow.
Available late 2024.
Cytology.
Morphology.
Easy-ology.
IDEXX inVue Dx Cellular Analyzer's automated, real-time cytology and blood morphology provide results with reference laboratory-level accuracy, within 10 minutes. Its slide-free workflow ensures consistency and accuracy without the time-consuming process of making slides. Multidimensional interrogation of cells in their natural state combined with multiple wavelengths of light and fluorescence illuminate unique elements in each cell, providing more diagnostic insight than traditional slide methods.
Blood morphology
Automated morphologic assessment of critical parameters, including these:
- Platelets even in the prescence of clumps
- Spherocytes
- Red blood cell agglutination
- Immature neutrophils
Integrated with hematology reports from ProCyte One and ProCyte Dx analyzers.
Ear cytology
Semiquantitative results of both left and right ears in one run for the following:
- Rod-shaped bacteria
- Cocci-shaped bacteria
- Yeast
Detects presence of:
- White Blood Cells
- Mites
Coming next—FNA: lumps and bumps
Brings objective data to subjective interpretation—identify, measure, and quantify cells like never before.†
A growing menu
The IDEXX inVue Dx analyzer is more than an analyzer, it’s a diagnostic platform that will have an ever-expanding menu.
See this first-of-its-kind analyzer in action.
Built and trained by IDEXX pathologists.
The IDEXX inVue Dx analyzer uses deep AI learning models trained by our global network of board-certified pathologists using tens of thousands of patient samples. This means you get objective results with quantitative diagnostic insights not possible by any other means, in real time.
We’re taking the work out of workflow.
Load and go, go, go. No more slides. No more time-consuming prep. No more subjectivity or inconsistencies. Get results in minutes. Yes, minutes. Giving you more time to focus on your patients.
Blood morphology
Ear cytology
Give valuable time back to your staff.
Slide-free, load-and-go workflow without the need to make and stain slides gives you and your staff time back. Time to move to the next task, take a breath, or see your next patient.
Easier to communicate results.
Communicate results and next steps with pet owners within the patient visit using the integrated report that includes diagnostic considerations.
Automatically capture results, images, and charges.
Results and the composite image gallery are automatically captured in patient records and VetConnect PLUS, making it easy to access previous results for patient follow-up. And automatic charge capture ensures nothing is missed.
A comprehensive in-house hematology picture.
The ProCyte One and ProCyte Dx hematology analyzers provide the comprehensive CBC you need. With the addition of the IDEXX inVue Dx analyzer and its automated blood morphology, you’ll have the complete story in just minutes.
Small size.
Big impact.
Depth: 13.5 in (34.3 cm)
Height: 12.2 in (30.9 cm)
Width: 9.3 in (23.6 cm)
A new member of your point-of-care team.
The IDEXX inVue Dx analyzer is designed and built to seamlessly connect with your IDEXX point-of-care analyzers, IDEXX Reference Laboratories, and VetConnect PLUS. Helping your practice run more efficiently and helping you stay focused on your patients.
†Fine needle aspiration (FNA) functionality is planned as a future platform enhancement.
Interested in seeing cells like never before?
Sign up to receive updates about IDEXX inVue Dx Cellular Analyzer as they become available.
Forward-looking statements
This web page, and the marketing content linked from this page, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including forward-looking statements regarding the launch and potential future menu and category expansions of the IDEXX inVue DxTM Cellular Analyzer. These forward-looking statements are intended to provide management's expectation of future events as of the date of this content; are based on management's estimates, projections, beliefs and assumptions as of the date of this content; and are not guarantees of future performance. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed in, or implied by, the forward-looking statements.
Those risks and uncertainties include, among other things, risks associated with developing and delivering new products and services, including menu expansion. The reports filed by IDEXX pursuant to U.S. securities laws (which are available from the SEC’s EDGAR database at sec.gov and via IDEXX’s website at idexx.com) also contain discussions of the risks, uncertainties and other factors that affect our business that you should carefully evaluate together with the forward-looking statements. No forward-looking statement can be guaranteed. You should not put undue reliance on any forward-looking statements, which speak only as of the date of this content. IDEXX assumes no obligation, and expressly disclaims any obligation, to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Any products, services, features or functionality referenced in this content that are not currently available may not be delivered on time or at all. Product roadmaps do not represent a commitment, obligation or promise to deliver any product, feature or functionality, and you should not rely on them to make your purchase decisions.